RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial – The Lancet

Invited commentary: Convalescent plasma in patients hospitalised with COVID-19

Commentaries on Twitter

Convalescent plasma:

Yet another example of

Don’t guess, don’t gamble

Randomize… and learn

I’ve heard it said that it was deemed “too difficult” to do a randomised controlled trial. Really? If that’s the case, we must (and can) fix that problem. Pts deserve better. https://t.co/zxIiK5U63v

— Martin Landray (@MartinLandray) May 15, 2021

NEW #COVID19 research—In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Read https://t.co/7Sbe8V9THp. #RECOVERY #RECOVERYtrial pic.twitter.com/D0OLZKxZc4

— The Lancet (@TheLancet) May 16, 2021